Document is current
Any future updates will be listed below
-
Authors
Iwata, Seigo
Nishiyama, Taisei
Sakari, Matomo
Doi, Yuki
Takaya, Naoki
Ogitani, Yusuke
Nagano, Hiroshi
Fukuchi, Keisuke
Miyako, Eijiro https://orcid.org/0000-0002-1157-6174
-
Funding
Funding for this research was provided by:
Daiichi Sankyo Company (N.A.)
MEXT | Japan Society for the Promotion of Science (23H00551, 22K18440)
MEXT | Japan Science and Technology Agency (JPMJTR22U1, JPMJSF2318, JPMJSP2102, JPMJSP2102)
Institute for Fermentation, Osaka (N.A.)
Uehara Memorial Foundation (N.A.)
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 16 June 2025
First Online: 5 August 2025
Competing interests
: E.M. is inventor on a patent application (WO2023223869A1) covering the anticancerous intratumoural bacteria. Y.O., H.N. and K.F. are the employees of Daiichi Sankyo Company, Limited. Y.O., H.N. and K.F. are shareholders of Daiichi Sankyo Company, Limited. This study was conducted as part of a collaborative research project with Daiichi Sankyo Company, Limited, which provided experimental and analytical support. However, the company was not involved in the interpretation of results or in the decision to publish. The other authors declare no competing interests.
